Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : email@example.com
AFM11 is a bi-specific antibody that targets CD19 and CD3, potentially resulting in enhanced anti-tumor immune response and decreased tumor growth (PMID: 25875246, PMID: 31090657).
|DrugClasses||CD19 Antibody 15 CD3 Antibody 75|
|CAS Registry Number||250245-29-5|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|